Live Breaking News & Updates on Fibrogen Shareholder Class Action Lawsuit

Stay updated with breaking news from Fibrogen shareholder class action lawsuit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcript

FibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcript November 6, 2023 FibroGen, Inc. beats earnings expectations. Reported EPS is $-0.52, expectations were $-0.68. Operator: Hello and welcome to the FibroGen’s Third Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator […] ....

John Hunter , Paul Choi , Djuan Graham , Pancreatic Cancer Action Network Precision Promise , Goldman Sachs , Society For Immunotherapy , Cancer Annual Meeting , Fibrogen China , Cancer Action Network Precision Promise , Activist Billionaire Paul Singer , Pancreatic Cancer , Metastatic Disease , Prostate Cancer , Thane Wettig , Djuan Graham ,

FibroGen Reports Third Quarter 2023 Financial Results

Topline data from two pivotal pamrevlumab pancreatic cancer trials on track to read out in 1H 2024, including the Pancreatic Cancer Action Network (PanCAN) Precision PromiseSM Phase 2/3 study in metastatic pancreatic cancer Third quarter net revenue of $40.1 million, an increase of 155% year over year Roxadustat sNDA accepted in China for chemotherapy-induced anemia Robust roxadustat volume growth of 37% in ChinaStrong execution of cost reduction plan reaffirming cash runway into 2026 SAN FRANCI ....

United States , South Africa , Meichiel Keenan , David Delucia , Society For Immunotherapy Of Cancer Annual Meeting , Corporate Communications , Fibrogen Inc , Exchange Commission , European Society For Medical Oncology Congress , Drug Administration , Pancreatic Cancer Action Network Pancan Precision Promise , China Health Authority , American Society Of Nephrology , Pancreatic Cancer Action Network , Thane Wettig , Chief Executive Officer , Key Events , Third Quarter , Chief Executive , New Drug Application , European Society , Medical Oncology Congress , American Society , Kidney Week , Cancer Annual Meeting , Fibrogen China ,

FibroGen, Inc. (NASDAQ:FGEN) Short Interest Up 8.9% in October

FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) saw a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 11,450,000 shares, a growth of 8.9% from the September 30th total of 10,510,000 shares. Based on an average daily trading volume, of 4,370,000 shares, the days-to-cover ratio […] ....

United States , Fibrogen Inc , Altshuler Shaham Ltd , Royal Bank , Daymark Wealth Partners , Get Free Report , Shaham Ltd , Fibrogen Daily , Nasdaq Fgen ,

Logos Global Management LP Decreases Stake in FibroGen, Inc. (NASDAQ:FGEN)

Logos Global Management LP cut its holdings in FibroGen, Inc. (NASDAQ:FGEN – Free Report) by 42.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 300,000 shares of the biopharmaceutical company’s stock after selling 225,000 shares during the […] ....

United States , Raymond James , Stifel Nicolaus , William Blair , Christine Chung , Exchange Commission , Healthcare Of Ontario Pension Plan Trust Fund , Securities Exchange Commission , Fibrogen Company Profile , Deutsche Bank , Ghost Tree Capital , Fibrogen Inc , Logos Global Management , Free Report , Global Management , Sigma Advisers , Sigma Investments , Tree Capital , Ontario Pension Plan Trust Fund , Get Free Report , Visit Holdingschannel , Fibrogen Daily , Nasdaq Fgen , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

FibroGen (FGEN) Announces Topline Results from LELANTOS-2

FibroGen (FGEN) Announces Topline Results from LELANTOS-2
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David Delucia , Michael Szumeraexternal Communications , Fibrogen Inc , Exchange Commission , Drug Administration , North Star Ambulatory Assessment , Thane Wettig , Interim Chief Executive Officer , About Duchenne Muscular Dystrophy , Orphan Drug Designation , Fast Track , Rare Pediatric Disease Designation , Looking Statements This , Annual Report , Quarterly Report , Michael Szumeraexternal ,